Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Assets: 2022-2024

Historic Assets for Orchestra BioMed Holdings (OBIO) over the last 3 years, with Dec 2024 value amounting to $76.2 million.

  • Orchestra BioMed Holdings' Assets rose 39.15% to $104.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $104.8 million, marking a year-over-year increase of 39.15%. This contributed to the annual value of $76.2 million for FY2024, which is 20.00% down from last year.
  • Per Orchestra BioMed Holdings' latest filing, its Assets stood at $76.2 million for FY2024, which was down 20.00% from $95.2 million recorded in FY2023.
  • In the past 5 years, Orchestra BioMed Holdings' Assets ranged from a high of $95.6 million in FY2022 and a low of $76.2 million during FY2024.
  • For the 3-year period, Orchestra BioMed Holdings' Assets averaged around $89.0 million, with its median value being $95.2 million (2023).
  • Data for Orchestra BioMed Holdings' Assets shows a maximum YoY fell of 20.00% (in 2024) over the last 5 years.
  • Orchestra BioMed Holdings' Assets (Yearly) stood at $95.6 million in 2022, then declined by 0.38% to $95.2 million in 2023, then dropped by 20.00% to $76.2 million in 2024.